Search

everythinglearnresearchcommunity

for

Search:↓

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Amphetamines may not directly cause hair loss, as the type of thinning seen with their use differs from severe alopecia.

Adolescents with severe alopecia incur significantly higher healthcare costs.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Both azathioprine and betamethasone treatments effectively regrow hair in alopecia areata, but azathioprine may be safer.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Ruxolitinib helped a man regrow his beard after years of hair loss.